文献速递心境障碍

多基因风险评分与电休克治疗结局的关联

Association Between Polygenic Risk Scores and Outcome of ECT.
PubMed 文献 · Am J Psychiatry · 2022-09-07

研究纳入2320例因重性抑郁发作接受电休克治疗的患者,探讨重性抑郁、双相障碍和精神分裂症的多基因风险评分与CGI-I改善的关联。结果显示重性抑郁PRS较高与CGI-I改善较少相关,双相障碍PRS较高与改善较多相关,精神分裂症PRS与改善无关联。

要点

  • 重性抑郁PRS每增加1个标准差,CGI-I改善的OR为0.89(95%CI=0.82,0.96)。
  • 双相障碍PRS每增加1个标准差,CGI-I改善的OR为1.14(95%CI=1.05,1.23)。
  • 精神分裂症PRS与CGI-I改善无关联。

核心结论

  • 电休克治疗后改善与重性抑郁和双相障碍的多基因易感性相关,为ECT临床反应的遗传成分提供了证据。

研究设计与样本

  • 2013至2017年邀请在瑞典国家ECT质量登记册中至少记录一个治疗系列的患者提供血样进行基因分型。
  • 纳入2320例因重性抑郁发作接受ECT系列、有登记治疗结局且可计算多基因风险评分的参与者(中位年龄51岁,62.8%女性,77.1%单相抑郁)。
  • 采用序数逻辑回归估计PRS对每个ECT系列后CGI-I评分的影响。

主要发现

  • 重性抑郁PRS较高与CGI-I改善较少显著相关(每标准差OR=0.89,95%CI=0.82,0.96;R2=0.004)。
  • 双相障碍PRS较高与CGI-I改善较多相关(每标准差OR=1.14,95%CI=1.05,1.23;R2=0.005)。
  • 精神分裂症PRS与改善无关联。
  • 在重叠样本(N=1,207)中,以自评版Montgomery-Åsberg抑郁评定量表定义应答和缓解,结果相似,但精神分裂症PRS也与缓解相关。

关键数值与推荐

  • 重性抑郁PRS每标准差OR=0.89(95%CI=0.82,0.96;R2=0.004)。
  • 双相障碍PRS每标准差OR=1.14(95%CI=1.05,1.23;R2=0.005)。
  • 精神分裂症PRS与CGI-I改善无关联。

临床怎么用

  • 这些易感性可在未来的ECT结局预测模型中与临床预测因素一起考虑。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Identifying biomarkers associated with response to electroconvulsive therapy (ECT) may aid clinical decisions. The authors examined whether greater polygenic liabilities for major depressive disorder, bipolar disorder, and schizophrenia are associated with improvement following ECT for a major depressive episode. METHODS: Between 2013 and 2017, patients who had at least one treatment series recorded in the Swedish National Quality Register for ECT were invited to provide a blood sample for genotyping. The present study included 2,320 participants (median age, 51 years; 62.8% women) who had received an ECT series for a major depressive episode (77.1% unipolar depression), who had a registered treatment outcome, and whose polygenic risk scores (PRSs) could be calculated. Ordinal logistic regression was used to estimate the effect of PRS on Clinical Global Impressions improvement scale (CGI-I) score after each ECT series. RESULTS: Greater PRS for major depressive disorder was significantly associated with less improvement on the CGI-I (odds ratio per standard deviation, 0.89, 95% CI=0.82, 0.96; R2=0.004), and greater PRS for bipolar disorder was associated with greater improvement on the CGI-I (odds ratio per standard deviation, 1.14, 95% CI=1.05, 1.23; R2=0.005) after ECT. PRS for schizophrenia was not associated with improvement. In an overlapping sample (N=1,207) with data on response and remission derived from the self-rated version of the Montgomery-Åsberg Depression Rating Scale, results were similar except that schizophrenia PRS was also associated with remission. CONCLUSIONS: Improvement after ECT is associated with polygenic liability for major depressive disorder and bipolar disorder, providing evidence of a genetic component for ECT clinical response. These liabilities may be considered along with clinical predictors in future prediction models of ECT outcomes.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Sigström R, Kowalec K, Jonsson L, et al. Association Between Polygenic Risk Scores and Outcome of ECT. Am J Psychiatry. 2022. PMID: 36069021. doi:10.1176/appi.ajp.22010045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。